基于网络的干预行动,以减轻2型糖尿病和肥胖的成年人的体重 (Chance2Act):非随机对照试验的协议
Noraini Mohd Saad1, Mariam Mohamad1, Aimi Nadira Mat Ruzlin1
1Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia.
JMIR research protocols
|January 31, 2024
概括
本研究介绍了Chance2Act,这是一项基于网络的干预措施,旨在帮助患有2型糖尿病 (T2D) 和肥胖症的成年人为减肥做好准备. 如果有效,它为肥胖管理中的行为改变提供了新的策略.
科学领域:
- 行为科学 行为科学
- 数字健康数字健康
- 内分泌学 在内分泌学.
背景情况:
- 减肥改善了2型糖尿病 (T2D) 的健康结果,包括HbA1c和血压.
- 许多肥胖的T2D患者还没有准备好开始减肥,这限制了干预的有效性.
- 关于数字健康干预对T2D中减肥行为变化的证据有限.
研究的目的:
- 开发和验证"Chance2Act",一个新的基于网络的干预.
- 促进2型糖尿病成年人肥胖的行为变化,这些成年人还没有准备好减肥.
- 通过非随机对照试验确定Chance2Act的有效性.
主要方法:
- 根据Transtheoretical模型,为患有肥胖症的T2D成年人开发基于网络的干预措施.
- 第一个阶段:干预开发和验证 (内容有效性指数,面部有效性指数).
- 第二阶段:非随机对照试验 (N=124) 将Chance2Act加常规护理与仅常规护理进行比较;主要结局是准备减肥.
主要成果:
- 预计第一阶段的有效性指数将超过0.83.
- 第二阶段将分析变化准备,自我效能,BMI和其他次要结果的差异.
- 第二阶段的数据分析将于2024年开始,预计结果将于2024年3月发布.
结论:
- 如果有效,Chance2Act可以为T2D肥胖症提供有价值的行为修改策略.
- 干预可以适应各种环境,以支持患者的行为变化.
- 这项研究增强了对整体T2D肥胖护理行为改变技术的理解.
相关概念视频
Carbohydrate Metabolism
11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Diabetes: Management and Pharmacotherapy
285
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285


